top of page
Biologics Raw Material Control: CMC Series XII—Supplier Qualification, Variability, and Adventitious-Agent Risk
Learn how to build a risk-based raw-material control strategy for biologics—from material attributes and supplier qualification to adventitious-agent risk, change management, and CTD evidence.
Jason Lu
Nov 112 min read
Biologics CMC Series (4): Biologics Control Strategy—Integrating Process, Analytics, and Regulatory Requirements
Biologics quality cannot rely on release testing alone. This guide explains how to build an integrated strategy across materials, manufacturing, analytics, specifications, and continued monitoring.
Jason Lu
Aug 3011 min read
bottom of page